Position in MYGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$340,121
-$67,678 QoQ
Shares Held
59,566
-34.3% QoQ
Ownership
0.062%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 196 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quantinno Capital Management LP holds $887,159,169 across 28 Diagnostics & Research names. MYGN ranks #26 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
670,767 | $117,940,961 | |
| 2 | A |
Agilent Technologies, Inc.
|
870,573 | $115,638,211 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
201,049 | $100,797,926 | |
| 4 | DHR |
Danaher Corp /De/
|
456,740 | $86,999,835 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
164,289 | $86,488,301 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
357,824 | $69,138,753 | |
| 7 | DGX |
Quest Diagnostics Inc
|
252,924 | $53,607,241 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
216,150 | $49,020,658 |
All Filings in MYGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $340,121 | 59,566 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $407,799 | 90,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $439,374 | 71,443 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $189,368 | 26,192 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $109,412 | 20,605 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||